◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Wakamoto Pharmaceutical Co.,Ltd. (4512) Financial History

Name: Wakamoto Pharmaceutical Co.,Ltd. (4512) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Wakamoto Pharmaceutical Co.,Ltd. (4512) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Tokyo, Japan with about 403 employees. Its market capitalization is roughly JPY 9 billion. In the fiscal year ended 2026-03-31, 4512 reported JPY 9.9B in revenue and JPY 227M in net income.

Wakamoto Pharmaceutical Co.,Ltd. is engaged in the manufacture and sale of pharmaceuticals, medical devices, and health food in Japan. It operates through four segments: Pharmaceutical Business, Healthcare Business, Global Business, and Real Estate Leasing Business.

Interactive charts & full statements →

4512 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 9.9B	JPY 7.8B	JPY 7.7B	JPY 8.7B	—
Gross Profit	JPY 4.7B	JPY 3.6B	JPY 3.6B	JPY 4.1B	—
Operating Income (EBIT)	JPY 256M	(JPY 458M)	(JPY 196M)	JPY 142M	—
Net Income	JPY 227M	JPY 64M	JPY 109M	JPY 138M	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4512 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 104M)	(JPY 103M)	(JPY 104M)	(JPY 0M)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4512 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 16.5B	JPY 15.0B	JPY 15.4B	JPY 15.7B	—
Total Liabilities	JPY 4.5B	JPY 3.4B	JPY 3.4B	JPY 3.8B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4512 viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

4574 · Taiko Pharmaceutical Co.,Ltd. — $13 billion
1681 · Consun Pharmaceutical Group Limited — $12 billion
2627 · Ab&B Bio-Tech CO., LTD. JS — $12 billion
4524 · Morishita Jintan Co., Ltd. — $9 billion
2186 · Luye Pharma Group Ltd. — $8 billion
0460 · Sihuan Pharmaceutical Holdings Group Ltd. — $8 billion
APTX · Apotex Health Corp. — $8 billion
0570 · China Traditional Chinese Medicine Holdings Co. Limited — $7 billion

← 4507 All “0-9” companies 4516 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.